WANBURYPharmaceuticals
Wanbury Ltd — Quarterly Results & Earnings
₹221.95
+0.00%
Profit Growth YoY1197.12%Latest quarter
Sales Growth YoY24.46%Latest quarter
Sales CAGR 5Y10.29%5 year compound
Profit CAGR 5Y30.94%5 year compound
📋
Quarterly Performance
YoY Profit Growth+1197.12%
🔥 Exceptional growth
YoY Sales Growth+24.46%
🔥 Exceptional growth
OPM 5Y Average
9.18%Operating profit margin
EPS Growth 5Y
27.81%Interest Coverage
2.14Higher = safer debt servicing
ROE
76.52%ROCE
36.68%💡
Growth Analysis
Wanbury Ltd reported YoY profit growth of 1197.12% and revenue growth of 24.46% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 10.29% and profits at 30.94% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Wanbury Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.